Immune Design (IMDZ) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures muted as oil holds near April highs ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts IMDZ Hot Sheet
Join SI Premium – FREE
Immune Design (NASDAQ: IMDZ) reported Q3 EPS of ($0.37), $0.02 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.1 million.
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SoFi Technologies (SOFI) Tops Q3 EPS by 1c, Offers Guidance
- Herc Holdings (HRI) Tops Q3 EPS by 95c ; Offers Guidance
- Applied Industrial Technologies (AIT) Tops Q1 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
